Effects of 1% Topical Brinzolamide on Intraocular Pressure in Healthy Dogs

Background: Glaucoma is one of the most common causes of blindness in dogs, and is generally characterized by death of the retinal ganglion cells associated with a rapid loss of vision. Increased intraocular pressure (IOP) occurs in patients with primary glaucoma, due to genetic abnormalities in pectinal ligaments and the trabeculae of the iridocorneal angle, producing inadequate drainage of aqueous humor. IOP is the result of the dynamic equilibrium between the production and drainage of aqueous humor. Intraocular surgery, anterior lens luxation, systemic diseases, immune-mediated, neoplastic and infectious diseases lead to the breakdown of the blood-aqueous barrier and increase the amount of protein and cells in aqueous humor, which can block this drainage pathway. Under these conditions, becomes indispensable the pharmacological control of IOP by reducing aqueous humor production. The main objective of the present study was to evaluate the effects of topical 1% brinzolamide on intraocular pressure (IOP) in twelve healthy dogs.Materials, Methods & Results: The age range of affected dogs was 1-5 years, with a mean age of 2.5 years. Twelve dogs were included in this study. All animals were healthy based on clinical, ophthalmic and hematological examinations. Selected animals were kept in a room with 500 lux luminosity, 56.8% relative humidity, 20°C temperature, exposed to 12 h of light/dark cycle, were fed twice daily and water ad libitum. All animals were adaptation to the procedures and examiners and IOP was measured by applanation tonometry at 08:00 a.m., 11:00 a.m., 02:00 p.m., 05:00 p.m., and 08:00 p.m., for 7 days and 2 days of baseline. Subsequently, one eye of each dog was randomly assigned, the eye received one drop of 1% brinzolamide at 08:30 a.m., 02:30 p.m., and 08:30 p.m. during four consecutive days and adelfo eyes received one drop of sterile saline solution and were considered control eyes. During the treatment phase and on the day after the treatment had finished, all parameters were evaluated in a blind fashion at the same pre-established time points. The value for IOP during the baseline of the treated eye were 16.77 ± 0.22 mmHg. The baseline period, values did not differ significantly between treated and control eyes. Comparison between the first day of brinzolamide-treated eyes with the average daily values of the two days of the baseline period showed that IOP decreased significantly 8.88%. IOP after four days of daily instillations of brinzolamide was able to decrease overall IOP by 1.42 mmHg (8.47%) when compared with the baseline period. Overall IOP values in the brinzolamide-treated eyes decreased 1.02 mmHg (6.24%) when compared to the control eyes. There were no statistically significant differences when compared control eye to baseline. Three times daily instillations of 1% brinzolamide in healthy dogs significantly decrease 8.47% IOP. During the post-treatment period, the average daily values of the brinzolamide-treated eyes remained 1.52 mmHg below the average daily values observed at baseline period.Discussion: The present research showed that, the average daily IOP values in the brinzolamide-treated eyes decreased 1.49 mmHg (8.88%) at the end of the first day, 1.69 mmHg (10.07%) at the end of the fourth day, and the cumulative IOP values after four days of treatment, were able to decrease by 1.42 mmHg (8.53%). Three times daily instillations of 1% brinzolamide in healthy dogs significantly decrease IOP, and therefore may be indicated to management of intraocular hypertension and glaucoma

Placa bloqueada e uso de antimicrobiano local no tratamento de fratura mandibular exposta em equino

A mandíbula é o osso da cabeça mais comumente fraturado nos equinos, sendo normalmente relacionada ao histórico de trauma. O objetivo deste relato é descrever um caso de fratura exposta de mandíbula em um equino com exsudação serossanguinolenta advinda de fístula localizada na região ventral do ramo horizontal da mandíbula esquerda. O diagnóstico foi realizado com base no histórico, sinais clínicos e avaliação radiográfica. Foi realizada osteossíntese com duas placas bloqueadas, ventral e lateral à mandíbula esquerda, associadas a antibioticoterapia de liberação lenta por meio de implante de cimento ósseo embebido em gentamicina para a estabilização do foco da fratura e controle da infecção no local respectivamente. Após quatro meses do procedimento cirúrgico foi observada consolidação da fratura óssea, sendo realizada a remoção das placas e do cimento ósseo implantados. O paciente recebeu alta médica com completo retorno de suas atividades e sem recidiva do processo infeccioso local

Fimose e parafimose decorrente de fibrose cicatricial em equinos – Relato de cinco casos

Objetivou-se a descrição do diagnóstico e tratamento cirúrgico de quatro casos de fimose e um caso de parafimose em cavalos, todos com histórico de laceração e formação de fibrose na região prepucial e pênis com pelo menos três meses de evolução. O diagnóstico preciso de fimose e parafimose devido à formação de tecido de granulação exuberante foi possível somente após a inspeção física local seguida de biópsia e análise histopatológica do tecido. O tratamento empregado de circuncisão e da ressecção cirúrgica do tecido de granulação exuberante da glande do pênis foram eficazes para resolução dos quadros clínicos. O pronto atendimento clínico adequado após a ocorrência da laceração do prepúcio e do pênis poderia ter evitado o desenvolvimento dos quadros clínicos de fimose e parafimose

Comparative study of clinical cardiorespiratory parameters and recovery times in bitches submitted to ovariohysterectomy and anesthetized with halothane, isoflurane or sevoflurane

Objetivou-se comparar os efeitos cardiorrespiratórios, bem como sobre a recuperação em cadelas submetidas à ovariosalpingohisterectomia, e anestesiadas pelo halotano, isofluorano ou sevofluorano. Para tanto, utilizaram-se vinte e quatro cadelas sem raça definida, com peso médio de 15,03 e idade média de 3,93 anos, clinicamente saudáveis, avaliadas por meio de hemograma completo, contagem de plaquetas, bioquímica hepática e renal e teste de coagulação, sendo distribuídas em três grupos de oito animais. Todos os animais receberam acepromazina na dose de 0,1 mg/kg i.m., como pré-tratamento e após 15 minutos a anestesia foi induzida com propofol na dose de 5 mg/kg i.v.. Para a manutenção utilizou-se halotano (grupo GAH), isofluorano (GAI) ou sevofluorano (GAS). Não houve diferença estatística entre os grupos em relação aos parâmetros cardiovasculares, observando redução discreta dos valores pressóricos após a indução, devido provavelmente a ação do propofol. A temperatura retal diminuiu gradativamente em função do tempo de anestesia, não apresentando diferença entre os grupos, porém GAI e GAS obtiveram valores inferiores dessa variável. Houve depressão respiratória nos três grupos, evidenciada pelo aumento da PaCO2 com consequente diminuição do pH arterial, porém sem diferença entre os grupos. O período obtido para extubação foi semelhante entre os grupos, no entanto, GAS apresentou menor tempo para posição quadrupedal comparado com GAH e GAI. A partir desses dados, conclui-se que diante dessa categoria animal e procedimento cirúrgico, o halotano, isofluorano e sevofluorano apresentaram características similares em relação aos parâmetros cardiovasculares, todos promoveram depressão respiratória e a recuperação foi mais rápida quando se optou pelo sevofluoranoThe cardiopulmonary effects and recovery times of halothane, isoflurane and sevoflurane were compared in bitches submitted to ovariohysterectomy. Twenty-four mongrel dogs were assigned in three groups of eight animals, with medium weight 15.03 kg and 3.93 years of age, designed groups GAH, GAI and GAS. All dogs received acepromazine (0.1 mg/kg, i.m.) as premedication and after 15 minutes, anesthesia was induced with propofol (5.0 mg/kg, i.v.) and maintenance anesthetics were halothane (GAH), isoflurane (GAI) and sevoflurane (GAS). No statistic difference was observed in cardiovascular parameters, but the SAP, DAP and MAP decreased slighty in moment M1 and this effect was associated with propofol. The rectal temperature decreased in function of the time of anesthesia, without difference among groups, but the AI and AS groups presented the lowest values of this parameter. Respiratory rate decreased in all groups, with an increase in the PaCO2 and a decrease in the pH, without statistic differences. The extubation times were similar in the three groups. Time to standing was shorter in the AS group when compared with the GAH and GAI groups. On the basis of the results, for this animal category and surgical procedure halothane, isoflurane and sevoflurane were similar in cardiovascular parameters. All agents caused respiratory depression and the recovery times were shorter in sevofluorano groupFAPES

Effects of dorzolamide/timolol and tafluprost on intraocular pressure and pupil diameter in healthy dogs

ABSTRACT: This study aimed to evaluate and compare the effects of the fixed combination of dorzolamide/timolol with those of tafluprost on intraocular pressure (IOP) and pupil diameter (PD) in healthy dogs (n=10). Two experiments were conducted with an interval of 30 days. In both, IOP and PD were assessed at 8, 11, 14, 17, and 20h. Parameters were evaluated during baseline, treatment period of four days, and one day of post-treatment. During treatment phase, IOP decreased by 0.74 (P<0.05), 1.88 (P<0.01), 2.94 (P<0.001), and 3.10mmHg (P<0.01), in dorzolamide/timolol-treated eyes; and by 1.50, 2.18, 2.14, and 2.18mmHg (P<0.001), in tafluprost-treated eyes. PD decreased by 0.24 (P<0.01), 0.32 (P<0.01), 0.49 (P<0.001), and 0.40mm (P<0.001), in dorzolamide/timolol treated eyes; and by 2.31, 2.55, 2.43, and 2.70mm (P<0.001), in tafluprost-treated eyes. Dorzolamide/timolol and tafluprost were able to decrease IOP and PD in healthy dogs. However, a cumulative effect of the fixed combination of dorzolamide/timolol was more effective in reducing IOP, than tafluprost. Comparisons between treatments showed that tafluprost was more effective in reducing PD throughout the treatment phase